Nitazoxanide Treatment for Giardiasis and Cryptosporidiosis in Children

Annals of Pharmacotherapy

Volumn 38, Issue 4, 2004, Pages 634-640

  Bailey, Jason M ^a   Erramouspe, John ^a  

^a IDAHO STATE UNIVERSITY   (United States)

Author keywords

Cryptosporidia; Giardia; Nitazoxanide

Indexed keywords

ACETYLSALICYLIC ACID; ANTIRETROVIRUS AGENT; AZITHROMYCIN; CARBAMAZEPINE; METRONIDAZOLE; NITAZOXANIDE; PAROMOMYCIN; TIZOXANIDE; VALPROIC ACID; WARFARIN;

ABDOMINAL PAIN; ANTIPROTOZOAL ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIARRHEA; DRUG ACTIVITY; DRUG APPROVAL; DRUG COATING; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG RESPONSE; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; GIARDIA LAMBLIA; GIARDIASIS; HEADACHE; HEALTH CARE COST; HUMAN; IMMUNOCOMPETENCE; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TABLET; VOMITING;

ANTI-BACTERIAL AGENTS; ANTIPROTOZOAL AGENTS; CHILD; CLINICAL TRIALS; CRYPTOSPORIDIOSIS; DRUG INTERACTIONS; GIARDIASIS; HUMANS; THIAZOLES;

EID: 1542744523     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D451     Document Type: Review

References (22)

1. Ortiz JJ, Ayoub A, Gargala G, Chegne NL, Favennec L. Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru. Aliment Pharmacol Ther 2001;15:1409-15.
2. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis 2001;184:103-6.
3. Nitazoxanide (Alinia) - a new anti-protozoal agent. Med Lett Drugs Ther 2003;45:29-31.
4. Package insert. Alinia (nitazoxanide). Tampa, FL: Romark Pharmaceuticals, November 2002.
5. Gilles HM, Hoffman PS. Treatment of intestinal parasitic infections: a review of nitazoxanide. Trends Parasitol 2002;18:95-7.
6. Diaz E, Mondragon J, Ramirez E, Bernal R. Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. Am J Trop Med Hyg 2003;68:384-5.
7. Favennec L, Jave Ortiz J, Gargala G, Lopez Chegne N, Ayoub A, Rossignol JF. Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru. Aliment Pharmacol Ther 2003;17:265-70.
8. Rossignol JF, Abaza H, Friedman H. Successful treatment of human fascioliasis with nitazoxanide. Trans R Soc Trop Med Hyg 1998;92:103-4.
9. Bicart-See A, Massip P, Linas MD, Datry A. Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS. Antimicrob Agents Chemother 2000;44:167-8.
10. Sisson G, Goodwin A, Raudonikiene A, Hughes NJ, Mukhopadhyay AK, Berg DE, et al. Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother 2002;46:2116-23.
11. Yamamoto Y, Hakki A, Friedman H, Okubo S, Shimamura T, Hoffman PS, et al. Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-Helicobacter pylori agent with anti-vacuolating toxin activity. Chemotherapy 1999;45:303-12.
12. McVay CS, Rolfe RD. In vitro and in vivo activities of nitazoxanide against Clostridium difficile. Antimicrob Agents Chemother 2000;44:2254-8.
13. Raether W, Hanel H. Nitroheterocyclic drugs with broad spectrum activity. Parasitol Res 2003;90(suppl 1):S19-39.
14. Stockis A, Deroubaix X, Lins R, Jeanbaptiste B, Calderon P, Rossignol JF. Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers. Int J Clin Pharmacol Ther 1996;34:349-51.
15. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis 2001;184:381-4.
16. Amadi B, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub A, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 2002;360:1375-80.
17. Rossignol JF, Hidalgo H, Feregrino M, Higuera F, Gomez WH, Romero JL, et al. A double-blind placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans R Soc Trop Med Hyg 1998;92:663-6.
18. Doumbo O, Rossignol JF, Pichard E, Traore HA, Dembele TM, Diakite M, et al. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa. Am J Trop Med Hyg 1997;56:637-9.
19. Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev 2001;14:114-28.
20. 2003 Drug topics red book. Montvale, NJ: Medical Economics, 2003.
21. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001;32:331-51.
22. Smith NH, Cron S, Valdez LM, Chappell CL, White AC Jr. Combination drug therapy for cryptosporidiosis in AIDS. J Infect Dis 1998;178:900-3.